Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07104383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Trial sites reduced: 134 → 127 locations
    v10
  2. Site details revised at 17 of 134 sitesv9
  3. Study sites: 130 to 134v8
  4. Site details revised at 2 of 130 sitesv7
  5. Study sites: 128 to 130v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 126 to 128v5
  2. Study sites: 124 to 126v4
  3. Study sites: 112 to 124v3
  4. Study sites: 94 to 112v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight
Trial Details
NCT Number NCT07104383
Lead Sponsor Viking Therapeutics, Inc.
Conditions
(from sponsor)		 Weight Loss
Related terms Weight Loss
Enrollment 1,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov